Cuprina Holdings (Cayman) Ltd Ordinary Shares - Class A CUPR

Morningstar Rating
$5.26 −0.01 (0.19%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

CUPR is trading at a 532% premium.
Price
$5.25
Fair Value
$8.27
Uncertainty
Ctww Gtc
1-Star Price
$58.37
5-Star Price
$2.45
Economic Moat
Bhzp
Capital Allocation

News

Trading Information

Previous Close Price
$5.27
Day Range
$4.756.48
52-Week Range
$1.7676.00
Bid/Ask
$5.05 / $5.10
Shares Outstanding
2.68M
Market Cap
$14.10M
Volume/Avg
532,251 / 2M

Key Statistics

Price/Earnings (Normalized)
Price/Sales
266.17
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Total Yield

Company Profile

Cuprina Holdings (Cayman) Ltd is a biomedical and biotechnology company that is dedicated to the development and commercialization of products for the management of chronic wounds, as well as operating in the health and beauty sector. It manufactured and distributed a line of medical grade sterile blowfly larvae bio-dressing products marketed under the MEDIFLY brand name, or the MEDIFLY products. The MEDIFLY products are used as a biological debridement tool for chronic wounds, in a procedure known as Maggot Debridement Therapy, or MDT, which is an effective alternative to surgical debridement.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Small Core
Total Number of Employees
10

Valuation

Metric
CUPR
Price/Earnings (Normalized)
Price/Book Value
2.71
Price/Sales
266.17
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
CUPR
Quick Ratio
1.08
Current Ratio
2.35
Interest Coverage
−313.90
Quick Ratio
CUPR

Profitability

Metric
CUPR
Return on Assets (Normalized)
−64.47%
Return on Equity (Normalized)
−164.28%
Return on Invested Capital (Normalized)
−147.86%
Return on Assets
CUPR

Medical Instruments & Supplies Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Intuitive Surgical Inc
ISRG
SpvqvhznTfmxw$146B
Becton Dickinson & Co
BDX
HdwbvCjzhbb$40B
Alcon Inc
ALC
WhhbfhysQdldrxt$33B
Medline Inc Ordinary Shares - Class A
MDLN
FfvrcbmtNnjfy$31B
ResMed Inc
RMD
JnpqblfpkCgynk$28B
West Pharmaceutical Services Inc
WST
QtgsklfljDfg$23B
Solventum Corp
SOLV
KrxbpspjTjfp$14B
The Cooper Companies Inc
COO
GvtmybqyxJttfvcd$13B
Align Technology Inc
ALGN
RcflkbhgWsylpq$13B
Baxter International Inc
BAX
KvpmGlvcz$11B

Sponsor Center